SPHK2 and breast carcinoma: A previous study in the Michigan Cancer Foundation-7 (MCF-7) breast cancer cell line showed phorbol myristate acetate-induced translocation of SPHK2 to the nucleus and generation of nuclear S1P, which inhibited HDAC activity [58].